Zomedica Pharmaceuticals Corp Stock Market Value
| ZOM Stock | USD 0.12 0 2.50% |
| Symbol | Zomedica |
Zomedica Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.06) | Revenue Per Share 0.027 | Quarterly Revenue Growth 0.018 | Return On Assets (0.09) | Return On Equity (0.24) |
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Zomedica Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zomedica Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zomedica Pharmaceuticals.
| 12/19/2023 |
| 12/13/2024 |
If you would invest 0.00 in Zomedica Pharmaceuticals on December 19, 2023 and sell it all today you would earn a total of 0.00 from holding Zomedica Pharmaceuticals Corp or generate 0.0% return on investment in Zomedica Pharmaceuticals over 360 days. Zomedica Pharmaceuticals is related to or competes with Tilray, Aurora Cannabis, Canopy Growth, OrganiGram Holdings, Shuttle Pharmaceuticals, Lifecore Biomedical, and Aquestive Therapeutics. Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products... More
Zomedica Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zomedica Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zomedica Pharmaceuticals Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 24.36 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 7.69 |
Zomedica Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zomedica Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zomedica Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Zomedica Pharmaceuticals historical prices to predict the future Zomedica Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.0005) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.1) |
Zomedica Pharmaceuticals Backtested Returns
Zomedica Pharmaceuticals shows Sharpe Ratio of -0.0122, which attests that the company had a -0.0122% return per unit of risk over the last 3 months. Zomedica Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zomedica Pharmaceuticals' Market Risk Adjusted Performance of (0.09), mean deviation of 1.76, and Standard Deviation of 3.93 to validate the risk estimate we provide. The firm maintains a market beta of 0.59, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Zomedica Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Zomedica Pharmaceuticals is expected to be smaller as well. At this point, Zomedica Pharmaceuticals has a negative expected return of -0.0491%. Please make sure to check out Zomedica Pharmaceuticals' jensen alpha and daily balance of power , to decide if Zomedica Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.05 |
Virtually no predictability
Zomedica Pharmaceuticals Corp has virtually no predictability. Overlapping area represents the amount of predictability between Zomedica Pharmaceuticals time series from 19th of December 2023 to 16th of June 2024 and 16th of June 2024 to 13th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zomedica Pharmaceuticals price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Zomedica Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Zomedica Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Zomedica Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Zomedica Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Zomedica Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Zomedica Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Zomedica Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Zomedica Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Zomedica Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Zomedica Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Zomedica Pharmaceuticals Lagged Returns
When evaluating Zomedica Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Zomedica Pharmaceuticals stock have on its future price. Zomedica Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Zomedica Pharmaceuticals autocorrelation shows the relationship between Zomedica Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Zomedica Pharmaceuticals Corp.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Zomedica Pharmaceuticals Correlation, Zomedica Pharmaceuticals Volatility and Zomedica Pharmaceuticals Alpha and Beta module to complement your research on Zomedica Pharmaceuticals. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Zomedica Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.